Roberts Glore & CO Inc Incyte Corp Transaction History
Roberts Glore & CO Inc
- $328 Million
- Q2 2024
A detailed history of Roberts Glore & CO Inc transactions in Incyte Corp stock. As of the latest transaction made, Roberts Glore & CO Inc holds 8,285 shares of INCY stock, worth $507,621. This represents 0.15% of its overall portfolio holdings.
Number of Shares
8,285
Previous 8,180
1.28%
Holding current value
$507,621
Previous $466,000
7.73%
% of portfolio
0.15%
Previous 0.14%
Shares
11 transactions
Others Institutions Holding INCY
# of Institutions
629Shares Held
198MCall Options Held
766KPut Options Held
476K-
Baker Bros. Advisors LP New York, NY30.7MShares$1.88 Billion24.77% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.31 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.4MShares$1.25 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA15.3MShares$936 Million0.58% of portfolio
-
State Street Corp Boston, MA10.9MShares$665 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $13.6B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...